These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4027138)

  • 1. Phenacetin O-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine?
    Kahn GC; Boobis AR; Brodie MJ; Toverud EL; Murray S; Davies DS
    Br J Clin Pharmacol; 1985 Jul; 20(1):67-76. PubMed ID: 4027138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking.
    Sesardic D; Boobis AR; Edwards RJ; Davies DS
    Br J Clin Pharmacol; 1988 Oct; 26(4):363-72. PubMed ID: 3190986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
    Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
    Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
    Murray S; Odupitan AO; Murray BP; Boobis AR; Edwards RJ
    Xenobiotica; 2001 Mar; 31(3):135-51. PubMed ID: 11465391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.
    Speirs CJ; Murray S; Boobis AR; Seddon CE; Davies DS
    Br J Clin Pharmacol; 1986 Dec; 22(6):739-43. PubMed ID: 3567021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of human cytochrome P-450.
    Guengerich FP; Umbenhauer DR; Churchill PF; Beaune PH; Böcker R; Knodell RG; Martin MV; Lloyd RS
    Xenobiotica; 1987 Mar; 17(3):311-6. PubMed ID: 3577206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man.
    Boobis AR; Murray S; Kahn GC; Robertz GM; Davies DS
    Mol Pharmacol; 1983 Mar; 23(2):474-81. PubMed ID: 6220203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.
    Distlerath LM; Reilly PE; Martin MV; Davis GG; Wilkinson GR; Guengerich FP
    J Biol Chem; 1985 Jul; 260(15):9057-67. PubMed ID: 4019462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies.
    Hietanen E; Bartsch H; Béréziat JC; Castegnaro M; Michelon J
    IARC Sci Publ; 1991; (115):297-304. PubMed ID: 1820345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver.
    Kronbach T; Mathys D; Gut J; Catin T; Meyer UA
    Anal Biochem; 1987 Apr; 162(1):24-32. PubMed ID: 3605590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity.
    Romkes-Sparks M; Mnuskin A; Chern HD; Persad R; Fleming C; Sibley GN; Smith P; Wilkinson GR; Branch RA
    Carcinogenesis; 1994 Sep; 15(9):1955-61. PubMed ID: 7923590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempts to phenotype human liver samples in vitro for debrisoquine 4-hydroxylase activity.
    Boobis AR; Hampden CE; Murray S; Beaune P; Davies DS
    Br J Clin Pharmacol; 1985 Jun; 19(6):721-9. PubMed ID: 4027115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenacetin O-deethylase activity of the rat: strain differences and the effects of enzyme-inducing compounds.
    Kahn GC; Rubenfield M; Davies DS; Boobis AR
    Xenobiotica; 1987 Feb; 17(2):179-87. PubMed ID: 3564533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver.
    Otton SV; Brinn RU; Gram LF
    Drug Metab Dispos; 1988; 16(1):15-7. PubMed ID: 2894945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver of the rat.
    Sesardic D; Edwards RJ; Davies DS; Thomas PE; Levin W; Boobis AR
    Biochem Pharmacol; 1990 Feb; 39(3):489-98. PubMed ID: 2306261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methoxyphenamine O-demethylase and 5-hydroxylase: a GLC-ECD assay to study their activities and their inhibition by debrisoquine and sparteine.
    Hawes EM; Roy SD; McKay G; Midha KK
    Pharmacol Ther; 1987; 33(1):73-7. PubMed ID: 3628478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.
    Bock KW; Schrenk D; Forster A; Griese EU; Mörike K; Brockmeier D; Eichelbaum M
    Pharmacogenetics; 1994 Aug; 4(4):209-18. PubMed ID: 7987405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies.
    Pelkonen O; Pasanen M; Kuha H; Gachalyi B; Kairaluoma M; Sotaniemi EA; Park SS; Friedman FK; Gelboin HV
    Br J Clin Pharmacol; 1986 Aug; 22(2):125-34. PubMed ID: 3756062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
    Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
    J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.